Schedule 13G ownership disclosure

ADVERUM BIOTECHNOLOGIES INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 · CUSIP: 00773U207

Event date: 2024-12-17

Filing-level shares
1,050,000.00
Percent of class
5.1%
  • Rush Ryan Bradford

    Shares: 1,050,000.00 · Class: 5.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002048956-24-000001
Form type
SCHEDULE 13G
Filer
Adverum Biotechnologies, Inc.
CIK
CIK 1501756
Filed
Dec 17, 2024
Reporting period
Dec 17, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub